Tirofiban: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Tirofiban. Educational only — not medical advice.
Labeled uses
Tirofiban hydrochloride injection is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
Source: FDA labeling via NIH DailyMed (set fa3ac570…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.